Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus.
about
ECHS1 interacts with STAT3 and negatively regulates STAT3 signalingScreening of hepatocyte proteins binding to F protein of hepatitis C virus by yeast two-hybrid systemNuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotypeHepatitis C virus targets over-expression of arginase I in hepatocarcinogenesisComparative mitochondrial proteomic analysis of hepatocellular carcinoma from patientsGlobal proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion.New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach.Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis.Phosphoproteome profiling using a fluorescent phosphosensor dye in two-dimensional polyacrylamide gel electrophoresis.Detection of novel biomarkers of liver cirrhosis by proteomic analysis.Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.Tropomyosin-based regulation of the actin cytoskeleton in time and space.Proteomic profiling of liver from Elaphe taeniura, a common snake in eastern and southeastern AsiaProteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.Capturing and identification of differentially expressed fucome by a gel free and label free approach.In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach.New insights into viral structure and virus-cell interactions through proteomics.Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma.Promising Urinary Protein Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients.High-dimensional biology to comprehend hepatocellular carcinoma.An integrated proteomic and transcriptomic approach to understanding azathioprine- induced hepatotoxicity in rat primary hepatocytes.Attenuation of enoyl coenzyme A hydratase short chain 1 expression in gastric cancer cells inhibits cell proliferation and migration in vitro.Hydrophobic triaryl-substituted β-lactams as activity-based probes for profiling eukaryotic enzymes and host-pathogen interactions.Small hepatitis B surface antigen interacts with and modulates enoyl-coenzyme A hydratase expression in hepatoma cells.Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer.NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma.Can proteomics lead to the discovery of real biomarkers for HCC?Toxicogenomics discrimination of potential hepatocarcinogenicity of non-genotoxic compounds in rat liver.Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tags.
P2860
Q24317798-7C479154-3477-4307-BBC1-8AA40B8AA25EQ24338755-F459EBA3-61AA-4ED9-8E5C-527846CD3B7EQ27305074-C1D26FEC-0FC3-489D-8647-2196ADF767AFQ27488846-09866DDE-02E7-4BD5-A471-B4605865B23AQ28289016-C1BE700C-FEA0-4F14-8854-C52F8E74E16AQ33250475-A995EF20-C795-4847-9771-EB36F261482DQ33266698-C8FC61CA-2058-4902-93FD-70F6983C3EB4Q33298434-A0AD21FF-15A5-46C4-AC76-D2739B49EB30Q33323235-23A9FC1C-3059-4106-A485-77045EC5C975Q33764377-2F7C7029-BD73-47A2-9070-CCFBC260396BQ33839571-E0BA5BBE-2971-462A-B727-0EBAB8276970Q33954802-5BDB3711-A2E1-4716-8336-623FB090A32BQ34390304-3CAF24CF-8C8D-4AF5-8150-666F36279064Q34609315-F2BA9986-67B2-4113-AE0C-4A675665E445Q34736000-5B796CB7-DD88-4A6E-B00E-76AA718DC5D9Q35017973-4750B1E2-E976-4CF1-A2CD-3D8E70C56CE5Q35170154-A8EEA269-10A5-41E4-B370-881785D7890AQ35268866-441FCD28-3D4C-4BBD-9DE7-7E9E3AE6AB23Q35722244-F879215A-416F-471D-AE96-92C39BE57ED7Q36227964-50E23138-6B97-4F71-92B5-09E2CA2FB952Q36227969-842611D1-23DA-4DD3-9B8F-1A4C20DDC81DQ36316587-0EB304A8-9A41-409B-BA80-8257F56397FEQ37087376-F6D9908F-E9CC-49B6-A541-B963CBA2454CQ38443595-966E42F3-F0E8-4CED-9251-DAA6BFFA985AQ38945747-53382887-CBC9-4207-BBD0-E7E100E4A03FQ38960657-1AD110B6-E4C7-4131-B9C6-F0E2C3BD540FQ39218861-10A16472-284C-4790-8890-38ECBF73795DQ39388922-025E143B-3557-4C03-8EB6-D43F0F4BC2C4Q40150329-904960DA-43BC-4B60-AA1A-B63D68BD583AQ41093191-216443DC-C12A-4037-A2BD-24E7444D0E1AQ41128802-1D6AB80B-5D74-49F6-BAFE-ABFD1B9DF8D2Q44776072-11FEAF36-F6D3-46D9-9239-84C29DE88D4DQ51610744-11F0937B-9B67-44F0-9874-CE93AFB366E5
P2860
Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Proteomic profiling of protein ...... fected with hepatitis C virus.
@ast
Proteomic profiling of protein ...... fected with hepatitis C virus.
@en
type
label
Proteomic profiling of protein ...... fected with hepatitis C virus.
@ast
Proteomic profiling of protein ...... fected with hepatitis C virus.
@en
prefLabel
Proteomic profiling of protein ...... fected with hepatitis C virus.
@ast
Proteomic profiling of protein ...... fected with hepatitis C virus.
@en
P2093
P356
P1433
P1476
Proteomic profiling of protein ...... fected with hepatitis C virus.
@en
P2093
Isao Sakaida
Kazuyuki Nakamura
Kiwamu Okita
Masaaki Oka
Motonari Takashima
Norio Iizuka
Shuji Terai
Toshifusa Toda
Yasuhiro Kuramitsu
Yuichiro Yokoyama
P304
P356
10.1002/PMIC.200300712
P577
2004-07-01T00:00:00Z